posted on 2023-06-02, 08:20authored byKarol Nowicki-Osuch, Lizhe Zhuang, Tik Shing Cheung, Emily L. Black, Neus Masqué-Soler, Ginny Devonshire, Aisling M. Redmond, Adam Freeman, Massimilliano di Pietro, Nastazja Pilonis, Wladyslaw Januszewicz, Maria O'Donovan, Simon Tavaré, Jacqueline D. Shields, Rebecca C. Fitzgerald
<p>Columnar cells of the stomach and esophageal IM have mosaic gastric and intestinal phenotypes. <b>A,</b> UMAP of columnar cells isolated from samples of NSCJ, NGC, NGB, ND, ileum, colon, rectum, BE, gastric metaplasia of esophagus, squamocolumnar junction between NE and BE, CIM, GIM, nonchronic atrophic gastritis, and chronic atrophic gastritis with color denoting cell types. The cell types were assigned using cells from normal tissue types. <b>B,</b> Scatter plot of log-normalized expression of intestinal (<i>GPA33</i>) and gastric (<i>MUC5AC</i>) markers in the selected tissue types. <b>C,</b> Coimmunofluorescent staining of the esophagus with BE with BE-IM and GIM shows coexpression of intestinal and gastric markers in both types of IM using lineage markers MUC5AC (gastric) and GPA33 (intestinal), and progenitor markers MUC6 (gastric) and OLFM4 (intestinal). White arrowheads denote selected goblet cells; dashed white lines indicate selected BE-IM and GIM crypts, for GIM samples: 1, a crypt with mixed gastric and intestinal phenotype; 2, a crypt with cells showing mosaic phenotype; 3, a crypt with features of complete IM; scale bar, 100 μm. See supplementary Figs. S8 and S9 for ND and NGC. Images are representative of 12 patients (NGC = 2, ND = 2, BE-IM = 4, and GIM = 4). <b>D,</b> UMAP with MuSiC-derived contribution of gastric and intestinal phenotypes to individual cells of the esophageal IM (top) and stomach IM (bottom). <b>E,</b> Violin plots of squamous, SMG, gastric, or intestinal phenotype contribution to cells from NGC, E-GM, BE-IM, BSCJ, NAG, CAG, GIM, CIM, and ND samples.</p>
Funding
Cancer Research UK (CRUK)
Medical Research Council (MRC)
Foundation for Canadian Studies in the United Kingdom (Canada-UK Foundation)
Intestinal metaplasia in the esophagus (Barrett's esophagus IM, or BE-IM) and stomach (GIM) are considered precursors for esophageal and gastric adenocarcinoma, respectively. We hypothesize that BE-IM and GIM follow parallel developmental trajectories in response to differing inflammatory insults. Here, we construct a single-cell RNA-sequencing atlas, supported by protein expression studies, of the entire gastrointestinal tract spanning physiologically normal and pathologic states including gastric metaplasia in the esophagus (E-GM), BE-IM, atrophic gastritis, and GIM. We demonstrate that BE-IM and GIM share molecular features, and individual cells simultaneously possess transcriptional properties of gastric and intestinal epithelia, suggesting phenotypic mosaicism. Transcriptionally E-GM resembles atrophic gastritis; genetically, it is clonal and has a lower mutational burden than BE-IM. Finally, we show that GIM and BE-IM acquire a protumorigenic, activated fibroblast microenvironment. These findings suggest that BE-IM and GIM can be considered molecularly similar entities in adjacent organs, opening the path for shared detection and treatment strategies.
Our data capture the gradual molecular and phenotypic transition from a gastric to intestinal phenotype (IM) in the esophagus and stomach. Because BE-IM and GIM can predispose to cancer, this new understanding of a common developmental trajectory could pave the way for a more unified approach to detection and treatment.See related commentary by Stachler, p. 1291.This article is highlighted in the In This Issue feature, p. 1275